Bronchiectasis

Internal Medicine Journal

Volumn 36, Issue 11, 2006, Pages 729-737

  King, P ^a,b,c   Holdsworth, S ^a,b   Freezer, N ^a   Holmes, P ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Aetiology; Bronchiectasis; Clinical features; Diagnosis; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; BRONCHODILATING AGENT; CORTICOSTEROID; GENTAMICIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AIRWAY; ANTIBIOTIC THERAPY; BRONCHIECTASIS; BRONCHITIS; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CHRONIC DISEASE; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FATIGUE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HEMOPTYSIS; HUMAN; IDIOPATHIC DISEASE; MORBIDITY; NONHUMAN; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PULMONARY REHABILITATION; RESPIRATORY FUNCTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINOSINUSITIS; SPIROMETRY; STANDARDIZATION; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT;

BRONCHIECTASIS; HUMANS;

EID: 33749869211     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01219.x     Document Type: Review

References (69)

1. Perry KMA, King DS. Bronchiectasis, a study of prognosis based on a follow-up of 400 cases. Am Rev Tuber 1940; 32: 153-60.
2. Barker AF, Bardana EJ Jr. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis 1988; 137: 969-78.
3. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002; 177: 200-204.
4. Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005; 90: 737-40.
5. Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med 2005; 4: 205-9.
6. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55: 635-42.
7. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M et al. Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 400-407.
8. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006 (in press).
9. Barker AF. Bronchiectasis. N Engl J Med 2002; 346: 1383-93.
10. Tannenberg J, Pinner M. Atelectasis and bronchiectasis: an experimental study concerning their relationship. J Thorac Surg 1942; 11: 571-82.
11. Lapa e Silva JR, Guerreiro D, Noble B, Poulter LW, Cole PJ. Immunopathology of experimental bronchiectasis. Am J Respir Cell Mol Biol 1989; 1: 297-304.
12. Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147: 6-15.
13. Wilson R, Roberts D, Cole P. Effect of bacterial products on human ciliary function in vitro. Thorax 1985; 40: 125-31.
14. Currie DC, Garbett ND, Chan KL, Higgs E, Todd H, Chadwick MV et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q J Med 1990; 76: 799-816.
15. Amitani R, Wilson R, Rutman A, Read R, Ward C, Burnett D et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 1991; 4: 26-32.
16. Eller J, Lapa e Silva JR, Poulter LW, Lode H, Cole PJ. Cells and cytokines in chronic bronchial infection. Ann N Y Acad Sci 1994; 725: 331-45.
17. King PT, Freezer NJ, Holmes PW, Holdsworth SR, Forshaw K, Sart DD. Role of CFTR mutations in adult bronchiectasis. Thorax 2004; 59: 357-8.
18. Divac A, Nikolic A, Mitic-Milikic M, Nagorni-Obradovic L, Petrovic-Stanojevic N, Dopudja-Pantic V et al. CFTR mutations and polymorphisms in adults with disseminated bronchiectasis: a controversial issue. Thorax 2005; 60: 85.
19. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162 (4 part 1): 1277-84.
20. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. J COPD 2005; 2: 27-34.
21. Greenstone MA, Rutman A, Hendry WF, Cole PJ. Ciliary function in Young's syndrome. Thorax 1988; 43: 153-4.
22. Friedman KJ, Teichtahl H, De Kretser DM, Temple-Smith P, Southwick GJ, Silverman LM et al. Screening Young syndrome patients for CFTR mutations. Am J Respir Crit Care Med 1995; 152: 1353-7.
23. Garcia-Corbeira P, Dal-Re R, Aguilar L, Garcia-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000; 18: 2173-6.
24. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL et al. Infections with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 896-8.
25. Hill SL, Mitchell JL, Burnett D, Stockley RA. IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax 1998; 53: 463-8.
26. Tsang KW, Lam SK, Lam WK, Karlberg J, Wong BC, Hu WH et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med 1998; 158: 1047-51.
27. el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997; 113: 755-60.
28. Cortet B, Flipo RM, Remy-Jardin M, Coquerelle P, Duquesnoy B, Remy J et al. Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 815-19.
29. Hassan WU, Keaney NP, Holland CD, Kelly CA. High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 308-10.
30. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995; 108: 955-61.
31. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998; 113: 1329-34.
32. Smith IE, Jurriaans E, Diederich S, Ali N, Shneerson JM, Flower CD. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax 1996; 51: 914-18.
33. Mackay IS, Cole PJ. Rhinisitis, sinusitis and associated chest disease. In: Mackay IS, Bull TR, eds. Rhinology, Scott-Brown's Otolaryntology. London: Butterworths; 1987; 61-90.
34. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005; 128: 739-45.
35. Mal H, Rullon I, Mellot F, Brugiere O, Sleiman C, Menu Y et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 1999; 115: 996-1001.
36. Currie DC, Cooke JC, Morgan AD, Kerr IH, Delany D, Strickland B et al. Interpretation of bronchograms and chest radiographs in patients with chronic sputum production. Thorax 1987; 42: 278-84.
37. McGuinness G, Naidich DP. CT of airways disease and bronchiectasis. Radiol Clin North Am 2002; 40: 1-19.
38. Sheehan RE, Wells AU, Copley SJ, Desai SR, Howling SJ, Cole PJ et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 2002; 20: 581-7.
39. Roberts HR, Wells AU, Milne DG, Rubens MB, Kolbe J, Cole PJ et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000; 55: 198-204.
40. Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax 1984; 39: 179-84.
41. Pang J, Chan HS, Sung JY. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax 1989; 44: 948-51.
42. Bahous J, Cartier A, Pineau L, Bernard C, Ghezzo H, Martin RR et al. Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. Bull Eur Physiopathol Respir 1984; 20: 375-80.
43. Angrill J, Agusti C, de Celis R, Rano A, Gonzalez J, Sole T et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002; 57: 15-19.
44. Pang JA, Cheng A, Chan HS, Poon D, French G. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis 1989; 139: 14-17.
45. Roberts DE, Cole P. Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection. Lancet 1980; 8172: 796-7.
46. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-23.
47. Pang G, Clancy R, Cong M, Ortega M, Zhigang R, Reeves G. Influenza virus inhibits lysozyme secretion by sputum neutrophils in subjects with chronic bronchial sepsis. Am J Respir Crit Care Med 2000; 161: 718-22.
48. Ahren IL, Karlsson E, Forsgren A, Riesbeck K. Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae. J Antimicrob Chemother 2002; 50: 903-6.
49. Rayner CF, Tillotson G, Cole PJ, Wilson R. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother 1994; 34: 149-56.
50. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst Rev 2003; (4): CD001392.
51. Lobue PA. Inhaled tobramycin: not just for cystic fibrosis anymore? Chest 2005; 127: 1098-101.
52. Lin HC, Cheng HF, Wang CH, Liu CY, Yu CT, Kuo HP. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am J Respir Crit Care Med 1997; 155: 2024-9.
53. Bush A, Rubin BK. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2003; 24: 737-48.
54. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756-62.
55. Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst Rev 2000; (2): CD000045.
56. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2001; (2): CD002996.
57. Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005; 60: 943-8.
58. Sheikh A, Nolan D, Greenstone M. Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst Rev 2001; (4): CD002155.
59. Rosen MJ. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 122-31S.
60. Kolbe J, Wells A, Ram FS. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev 2000; (2): CD000996.
61. Agasthian T, Deschamps C, Trastek VF, Allen MS, Pairolero PC. Surgical management of bronchiectasis. Ann Thorac Surg 1996; 62: 976-8; discussion 979-80.
62. Balkanli K, Genc O, Dakak M, Gurkok S, Gozubuyuk A, Caylak H et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur J Cardiothorac Surg 2003; 24: 699-702.
63. Yankaskas JR, Mallory GB Jr. Lung transplantation in cystic fibrosis: consensus conference statement. Chest 1998; 113: 217-26.
64. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105: 1155-62.
65. Ashour M, Al-Kattan K, Rafay MA, Saja KF, Hajjar W, Al-Fraye AR. Current surgical therapy for bronchiectasis. World J Surg 1999; 23: 1096-104.
66. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2000; (4): CD002733.
67. Holland AE, Denehy L, Ntoumenopoulos G, Naughton MT, Wilson JW. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 2003; 58: 880-84.
68. Non-invasive ventilation in acute respiratory failure. Thorax 2002; 57: 192-211.
69. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 1997; 10: 2784-7.